- Trial site
Trial site location from the registry's own city and country
Clinical trial site
University Hospital of Patras
University Hospital of Patras in Pátrai, Achaḯa, Greece is listed as a site for 10 registered clinical trials, 10 of them ongoing.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
This page covers the site record University Hospital of Patras in Pátrai, Achaḯa, Greece: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University Hospital of Patras, also sponsors trials.
Trials by phase
Registered trials that list this site, by trial phase. 10 trials counted.
-
Phase 2/3 1 trial
-
Phase 3 9 trials
Trials by status
The registry's own status summary: Ongoing, Completed, Terminated or Other.
-
Ongoing 10 trials
Trials over time
Trials registered with a start date in each year, 1990 onward, most recent years first.
Trials over time, by phase
- Phase 3
Top of scale: 3
Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 3 |
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 1 |
| 2014 | 1 |
2026 is partial: trials registered with a 2026 start date so far, not a full year
Recent trials
The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.
Showing 5 of 10 trials.
Lead sponsors
Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
-
Eli Lilly and Company 4 trials
-
Bristol-Myers Squibb 3 trials
-
Pfizer 2 trials
Conditions studied
The specific conditions of the trials that list this site, most trials first.
Showing 5 of 10 conditions.